Boston Scientific Corp (NYSE:BSX)
| 13.14 Data as of Jul 30 |  +0.25 / +1.94%Today’s Change | 10.54 Today|||52-Week Range 14.08 | +9.32% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Capello Jeffrey D Chief Financial Officer & Executive Vice President |  Sale | 8/29/2013 | 388,462 | $10.67 | $4.1M | +23.26% |
Capello Jeffrey D Chief Financial Officer & Executive Vice President | Sale | 11/25/2013 | 242,504 | $12.02 | $2.9M | +10.51% |
Capello Jeffrey D Chief Financial Officer & Executive Vice President |  Buy | 8/29/2013 | 388,462 | $7.41 | $2.9M | +23.26% |
Mahoney Michael F President & Chief Executive Officer | Sale | 11/01/2013 | 161,268 | $11.75 | $1.9M | +11.83% |
Capello Jeffrey D Chief Financial Officer & Executive Vice President | Sale | 11/22/2013 | 150,000 | $12.02 | $1.8M | +9.05% |
Dawkins Keith D Exxecutive Vice President | Sale | 11/21/2013 | 138,850 | $12.00 | $1.7M | +10.14% |
Mario Ernest Director | Sale | 11/08/2013 | 115,200 | $11.73 | $1.4M | +10.61% |
Capello Jeffrey D Chief Financial Officer & Executive Vice President | Sale | 11/27/2013 | 108,595 | $11.70 | $1.3M | +12.21% |
Pucel Kenneth J EVP-Global Operations, Qulity & Technology | Sale | 2/19/2014 | 78,000 | $13.32 | $1.0M | +0.61% |
Capello Jeffrey D Chief Financial Officer & Executive Vice President | Sale | 11/26/2013 | 85,106 | $11.82 | $1.0M | +12.02% |
Page of 24
.
